Rare diseases
Investigational molecules
Locations
Back to the Netherlands5 clinical trials in Vlissingen, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on developing enhanced treatment strategies for rectal cancer recurrence, evaluating the effectiveness of combined therapeutic approaches including chemotherapy and radiotherapy.
Clinical trials aim to improve surgical outcomes and establish optimal treatment sequences for patients with locally recurrent disease.
Innovative trials exploring the potential of targeted therapies in HER2-positive esophageal cancer, combining established treatments with novel therapeutic antibodies.
Research focuses on enhancing patient outcomes through the integration of targeted biological therapies with standard treatment protocols.
Studies investigating the role of biomarker-driven treatments in gastrointestinal cancers, with particular emphasis on molecular targeting and personalized therapeutic strategies.
These trials aim to advance our understanding of targeted treatments and their impact on patient survival rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
